What Is Geographic Atrophy?

Understanding Geographic Atrophy and Wet AMD

What Is Geographic Atrophy?

Geographic atrophy is an advanced form of dry AMD where light-sensing cells in the macula slowly die. This progressive process creates blind spots in the central vision that gradually expand over time, making everyday tasks like reading and recognizing faces increasingly difficult.

Geographic atrophy occurs when the macula, the central part of the retina responsible for sharp central vision, develops areas where retinal cells have permanently died. These patches appear pale and have well-defined borders when viewed during an eye examination, which is why they are called geographic. As these patches grow larger over months to years, central vision becomes increasingly blurry or dim, making it difficult to read, drive, or recognize faces. However, peripheral vision remains unaffected, which means you can still navigate familiar spaces and maintain some independence even as the condition progresses.

Several factors increase your risk of developing geographic atrophy. While age is the primary factor, genetics and lifestyle also play a significant role. Understanding these risk factors can help you take steps to protect your vision.

  • Age over 60 years, with risk increasing significantly after age 75
  • Family history of AMD or geographic atrophy in parents or siblings
  • Smoking or a history of smoking, which doubles or triples the risk
  • High blood pressure or cardiovascular disease that affects blood flow to the eyes
  • Diet low in green leafy vegetables and antioxidants
  • Light eye color, particularly blue or green eyes
  • Excessive sun exposure over many years without proper eye protection
  • Having certain genetic variations that affect immune system function in the retina

Geographic atrophy symptoms develop gradually and may include blurry or dim spots in the center of your vision that slowly expand. Reading small print becomes increasingly difficult, and you may need brighter light or magnification to see clearly. Recognizing faces from a distance becomes challenging, and colors may appear less vibrant or washed out. Many people first notice problems when trying to read in dim lighting, when doing detailed work like sewing or cooking, or when they find themselves moving their eyes around to see around the blind spot. Because the progression is slow, some people adapt without realizing how much vision they have lost until the condition is more advanced.

Our ophthalmologists at ReFocus Eye Health Hatboro use several advanced imaging techniques to diagnose and monitor geographic atrophy. Optical coherence tomography (OCT) creates detailed cross-sectional images of the retina to measure thickness and identify areas of cell loss with remarkable precision. Fundus autofluorescence photography highlights areas of retinal damage by detecting natural fluorescence from the retinal cells. Color fundus photography provides a comprehensive view of the retina and helps document the size and location of atrophic patches. These tests, along with a comprehensive eye exam and visual acuity testing, allow your doctor to track the progression of the disease, evaluate your eligibility for treatment, and rule out other conditions that may cause similar symptoms.

AREDS2 supplements containing specific doses of vitamins C and E, zinc, copper, lutein, and zeaxanthin have been scientifically proven to slow progression in many patients with intermediate AMD or advanced AMD in one eye. The recommended daily doses are 500 milligrams of vitamin C, 400 international units of vitamin E, 80 milligrams of zinc, 2 milligrams of copper, 10 milligrams of lutein, and 2 milligrams of zeaxanthin. A diet rich in leafy greens like spinach, kale, and collard greens provides natural sources of lutein and zeaxanthin. Omega-3 fatty acids from fish like salmon, tuna, and mackerel may also support retinal health. Controlling blood pressure and cholesterol, maintaining a healthy weight, protecting your eyes from UV light with sunglasses, and avoiding smoking are also crucial for protecting your vision and slowing the progression of AMD.

Recent FDA-approved therapies represent the first treatments specifically designed for geographic atrophy. Pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay) are injectable treatments that target specific proteins in the immune system to slow the death of retinal cells. These injections are given monthly or every other month directly into the eye after it is numbed with anesthetic drops. Clinical studies show these treatments can slow the growth of atrophic areas by approximately 20 to 35 percent compared to no treatment, but they cannot reverse existing damage or restore vision that has already been lost. Your eye doctor will determine if you are a candidate for these therapies based on the location and size of the atrophic patches, your overall eye health, and your individual risk factors. It is important to understand that while these treatments slow progression, they require an ongoing commitment to regular injections and monitoring.

A wide variety of tools can help you maximize your remaining vision and maintain independence in daily activities. Magnifying glasses with built-in lights are helpful for reading, while handheld electronic magnifiers offer adjustable magnification and contrast settings. Computer screen-reading software can enlarge text and read it aloud, making it easier to use computers and tablets. Talking devices, large-button phones, and high-contrast keyboards can also make daily tasks easier and safer. Many tablets and smartphones have built-in accessibility features like voice-over, magnification, and high-contrast displays that can be customized to your needs. Specialized lighting, such as task lights with adjustable brightness, can make a significant difference in your ability to perform detailed activities. Reading stands that hold books or tablets at the right angle can reduce eye strain and improve comfort.

Professional vision rehabilitation teaches practical strategies for using your remaining vision most effectively and adapting to changes as the condition progresses. Occupational therapists can assess your home and work environments and suggest modifications for safety and efficiency, such as improving lighting, using contrasting colors to mark steps and edges, removing tripping hazards, and organizing frequently used items in accessible locations. They can also teach you how to use low vision aids effectively and develop techniques for completing daily tasks. Additionally, they can connect you with community resources, transportation services, and support groups where you can meet others facing similar challenges. Sharing experiences and coping strategies with others who understand what you are going through can provide emotional support and practical advice that makes a real difference in your quality of life.

What Is Wet AMD?

What Is Wet AMD?

Wet AMD, also called neovascular AMD, involves abnormal blood vessels growing under the macula and leaking fluid or blood, causing rapid damage to central vision. While it progresses much more quickly than geographic atrophy, it often responds well to prompt treatment with anti-VEGF injections.

Wet AMD occurs when new, fragile blood vessels form under the retina in response to a protein signal and then leak fluid and blood. This leakage causes swelling, bleeding, and scarring that damages the macula, leading to distorted or wavy vision and blind spots in the central visual field. Unlike dry AMD and geographic atrophy, wet AMD can progress rapidly, sometimes causing significant vision loss in just days or weeks if left untreated, which is why any sudden vision change requires immediate medical attention. The abnormal blood vessels can grow in different patterns and locations, which affects both the symptoms you experience and the treatment approach your doctor recommends. Early detection and treatment are critical for preserving as much vision as possible.

Wet AMD develops when the body produces too much of a protein called vascular endothelial growth factor (VEGF), which stimulates abnormal blood vessel growth under the retina. This typically happens in response to stress or damage to the retinal cells. Risk factors for developing wet AMD are similar to those for geographic atrophy.

  • Age over 60 years
  • Family history of AMD
  • Smoking or history of smoking
  • High blood pressure or cardiovascular disease
  • Previous dry AMD, including the presence of large drusen (yellow deposits under the retina)
  • Being female, as women tend to live longer and are therefore more likely to develop AMD
  • Obesity or being overweight
  • Excessive sun exposure throughout life without eye protection
  • Race, as wet AMD is more common in Caucasians than in other ethnic groups

Wet AMD symptoms can develop suddenly and progress rapidly, making early recognition critical. The most common and distinctive symptom is straight lines appearing wavy, bent, or distorted, which is especially noticeable when looking at door frames, window blinds, or lines of text. A central gray, black, or empty area may develop suddenly in your vision, making it difficult to see faces or read. Colors may appear washed out or less vivid than before. Objects may appear smaller or larger than they actually are, or they may seem closer or farther away than they really are. Some people notice a sudden increase in blurry central vision that does not improve with glasses. Any sudden change in your vision, especially distorted or wavy lines, requires immediate evaluation by an eye care professional, as treatment is most effective when started quickly.

Diagnosing wet AMD requires specialized tests to visualize fluid and leakage in the retina. Optical coherence tomography (OCT) creates detailed cross-sectional images showing fluid accumulation, retinal swelling, and the exact location of abnormal blood vessels. Fluorescein angiography involves injecting a harmless yellow dye into a vein in your arm and then photographing its flow through the blood vessels in your eye to identify leaking areas and determine the pattern of abnormal vessel growth. OCT angiography is a newer technology that can show blood vessel abnormalities without requiring an injection. Your eye doctor may also perform an Amsler grid test, where you look at a grid of lines to identify areas of distortion or missing spots. These tests together allow for a quick and accurate diagnosis, which is essential for starting treatment as soon as possible to preserve your vision.

Anti-VEGF drugs are the standard and most effective treatment for wet AMD. Medications such as ranibizumab (Lucentis), aflibercept (Eylea), brolucizumab (Beovu), and faricimab (Vabysmo) work by blocking the VEGF protein that causes abnormal blood vessel growth and leakage. These injections are given directly into the eye after it is thoroughly numbed with anesthetic drops and cleaned with an antiseptic solution. While this sounds intimidating, the procedure is quick, usually taking less than a minute, and is generally painless for most patients. The medication works by stopping the growth of new abnormal vessels and reducing fluid leakage, which helps stabilize or even improve vision. Most patients experience stabilized vision or even improved vision with regular treatment. Some patients notice vision improvement within days of their first injection, while others see gradual improvement over several weeks or months. The key to success is consistency and adherence to the recommended treatment schedule.

Treatment typically begins with monthly injections for the first few months to bring the disease under control and reduce fluid buildup. After this initial phase, your doctor will use OCT scans and vision tests at each visit to determine if the treatment is working and to adjust the schedule accordingly. Some patients may be able to extend the time between injections to every two or three months, while others require ongoing monthly treatment to keep the disease inactive. Newer medications like faricimab are designed to be effective for longer periods, potentially allowing for injections every three to four months for some patients. Regular follow-up appointments are crucial because wet AMD can reactivate even after successful treatment, and early detection of reactivation allows for prompt intervention. Adhering to your recommended treatment schedule and attending all follow-up visits gives you the best chance of preserving your sight and maintaining your quality of life.

While anti-VEGF injections are the first-line treatment, other options may be considered in specific situations. Photodynamic therapy (PDT) uses a light-activated drug to destroy abnormal blood vessels and may be combined with anti-VEGF therapy in certain cases. Laser photocoagulation can seal leaking blood vessels but is rarely used today because it causes permanent damage to the retina and is only suitable for lesions located away from the center of the macula. Researchers are also investigating new treatments, including gene therapy that could provide long-lasting effects from a single treatment, implantable devices that slowly release medication over months, and combination therapies that target multiple pathways involved in wet AMD. Your eye doctor will discuss which treatment approach is best for your specific situation based on the location and characteristics of the abnormal blood vessels, your overall eye health, and your individual needs and preferences.

Frequently Asked Questions

Frequently Asked Questions

Below are answers to common questions about geographic atrophy and wet AMD to help you understand these conditions and your care options at ReFocus Eye Health Hatboro.

Using an Amsler grid daily is one of the most effective ways to monitor for changes in your central vision. Cover one eye and look at the central dot on the grid while holding it at normal reading distance. If any lines appear wavy, blurry, bent, or dark, or if any areas are missing or distorted, contact your eye doctor immediately. You can obtain an Amsler grid from your eye doctor or print one from a reputable source online. This simple test takes less than a minute and can help detect the earliest signs of wet AMD or progression of geographic atrophy. Checking each eye separately is important because your brain can compensate when both eyes are open, potentially masking changes in one eye.

Yes, a person with geographic atrophy can still develop wet AMD in the same eye or in the other eye. Having any form of AMD increases your risk of developing wet AMD. This is why regular monitoring with comprehensive eye exams and advanced imaging is essential for anyone with an AMD diagnosis. Our ophthalmologists will watch for signs of new blood vessel growth during your exams so that treatment can begin immediately if wet AMD develops. The transition from dry to wet AMD can happen suddenly, which is why monitoring your vision at home with an Amsler grid and reporting any changes promptly is so important. Early detection and treatment of wet AMD can make a significant difference in preserving your vision.

Treatment outcomes vary depending on the type of AMD, how quickly treatment begins, and individual factors. For wet AMD, anti-VEGF injections can improve vision in approximately 30 to 40 percent of patients and stabilize it in about 90 percent, but a complete return to normal vision is uncommon. The best outcomes occur when treatment starts early, before significant damage has occurred. For geographic atrophy, current treatments with pegcetacoplan or avacincaptad pegol can slow progression but cannot reverse existing damage or restore lost vision. The goal of all treatments is to preserve as much vision as possible for as long as possible and to maintain your quality of life and independence. Even if vision cannot be fully restored, low vision aids and rehabilitation services can help you make the most of your remaining vision.

Anti-VEGF injections are very safe and have been used successfully for nearly two decades, but like all medical procedures, they do have risks. Common, mild side effects include temporary eye discomfort or scratchiness, redness that typically resolves within a day or two, and seeing floaters or small spots that usually go away on their own. Some patients experience a temporary increase in eye pressure immediately after the injection, which your doctor monitors. Serious complications like infection (endophthalmitis), retinal detachment, or bleeding inside the eye are very rare, occurring in less than 1 in 1,000 to 1 in 2,000 cases. Your doctor uses sterile techniques, including cleaning the eye surface with an antiseptic and using sterile instruments, to minimize these risks. The benefits of preserving your vision far outweigh the small risks for most patients with wet AMD.

Because AMD affects central vision while leaving peripheral vision intact, it can make detailed tasks that require sharp central vision very difficult or impossible. Reading road signs, seeing traffic lights, recognizing pedestrians, and following lane markings become challenging and unsafe. Many people with advanced AMD must stop driving for their own safety and the safety of others. Reading print becomes difficult as words in the center of your vision may appear blurry, distorted, or missing. However, low vision aids such as magnifiers with lights, electronic magnification devices with adjustable contrast, large-print books, and audiobooks can help you continue enjoying reading and other activities. Many people with AMD can continue to navigate familiar spaces safely using their peripheral vision, maintain social connections, and participate in activities they enjoy with the help of adaptive strategies and assistive devices.

Ongoing treatments like anti-VEGF injections can be costly, with each injection costing thousands of dollars without insurance. Most insurance plans, including Medicare, cover FDA-approved treatments for wet AMD because they are considered medically necessary to prevent vision loss. Geographic atrophy treatments with pegcetacoplan and avacincaptad pegol are also typically covered by Medicare and most insurance plans. However, you may still be responsible for copays, coinsurance, or deductibles depending on your specific insurance plan. Patient assistance programs are often available from drug manufacturers to help offset costs for those who qualify based on income and insurance status. Our staff at ReFocus Eye Health Hatboro can help you understand your insurance coverage and connect you with financial assistance resources if needed. Do not let financial concerns prevent you from seeking treatment, as options are usually available to help manage costs.

Yes, telemedicine and remote monitoring are becoming more common in AMD care and offer convenient options for patients. Some eye care practices offer remote monitoring programs where patients use a special device at home to perform vision tests and check for changes in their central vision. This data is transmitted securely to your doctor, allowing for earlier detection of disease activity or progression between regular office visits. Home monitoring can be especially helpful for patients who have difficulty traveling frequently to the office or who live in areas distant from specialized eye care. However, remote monitoring does not replace the need for regular comprehensive eye exams and in-person visits, as certain tests and treatments can only be performed in the office. Ask our team about home monitoring options that may be appropriate for your situation.

Vision loss can lead to feelings of frustration, anxiety, sadness, and depression, which are normal reactions to a significant life change. It is important to seek support and not try to cope alone. Talk openly with your family and friends about your challenges and needs so they can provide appropriate support. Consider connecting with a local or online support group for people with low vision or AMD, where you can share experiences, learn coping strategies, and receive encouragement from others who truly understand what you are going through. Speaking with a counselor or therapist who specializes in adjustment to disability or chronic illness can provide valuable tools for managing emotions and adapting to changes. Vision rehabilitation services not only provide practical tools and training but also offer emotional support and strategies for adapting to life with vision loss. Remember that vision loss does not mean loss of independence or quality of life, and many resources are available to help you continue living fully and actively.

Research for both geographic atrophy and wet AMD is very active, with numerous clinical trials investigating new treatments. For wet AMD, researchers are studying gene therapy approaches that could provide long-lasting effects from a single treatment, longer-acting anti-VEGF medications that reduce injection frequency, implantable drug delivery devices, and combination therapies that target multiple disease pathways. For geographic atrophy, trials are exploring additional complement inhibitors, neuroprotective agents that protect retinal cells, and stem cell therapies. Participating in a clinical trial may give you access to emerging therapies before they become widely available, contribute to advancing medical knowledge, and receive close monitoring at no cost. However, clinical trials also have requirements and potential risks that should be carefully considered. You can discuss whether a clinical trial is a good option for you with your eye care provider, who can help you understand the potential benefits and risks based on your specific situation.

You should seek immediate eye care for any sudden or rapid change in your vision. Warning signs that require urgent attention include straight lines suddenly appearing wavy, bent, or distorted, a new dark or blind spot in your central vision, a rapid decrease in sharpness or clarity of your central vision, sudden onset of many new floaters or flashes of light, or a curtain or shadow blocking part of your vision. These are all potential signs of wet AMD or other serious eye conditions such as retinal detachment, and early treatment provides the best chance of preserving your vision. Even if symptoms occur outside of regular office hours, contact your eye doctor or seek care at an emergency eye clinic. For patients from the Greater Philadelphia Metropolitan Area, including Montgomery, Bucks, Philadelphia, and Delaware Counties, ReFocus Eye Health Hatboro is equipped with advanced diagnostic technology to evaluate urgent eye concerns promptly and begin appropriate treatment when needed.

Taking Care of Your Eyes

Regular comprehensive eye exams are essential for early detection and management of AMD, allowing our ophthalmologists to identify changes before you notice symptoms and begin treatment at the most effective stage. Healthy lifestyle habits, including not smoking, eating a nutritious diet rich in leafy greens and fish, maintaining a healthy weight, controlling blood pressure and cholesterol, and protecting your eyes from UV light with sunglasses, all support long-term vision health. If you notice any changes in your vision, schedule an appointment promptly with ReFocus Eye Health Hatboro to preserve your sight and maintain your quality of life for years to come.

Contact Us

Google review
()

Monday: 8AM-4PM
Tuesday: 8AM-4PM
Wednesday: 8AM-4PM
Thursday: 8AM-4PM
Friday: 8AM-4PM
Saturday: Closed
Sunday: Closed